POTENTIAL FALSE‐POSITIVE RESULTS WITH ANTIGEN ENHANCEMENT FOR IMMUNOHISTOCHEMISTRY OF THE p53 GENE PRODUCT IN COLORECTAL NEOPLASMS
Inge O. Baas(Johns Hopkins University), G. Johan A. Offerhaus(Amsterdam UMC Location University of Amsterdam), Jan‐Willem R. Mulder(Amsterdam UMC Location University of Amsterdam), Robbert J.C. Slebos(University of Iowa), Stanley R. Hamilton(City of Hope), Frank M. van den Berg(Amsterdam UMC Location University of Amsterdam), Marjon J. Clement(Johns Hopkins University)
The Journal of Pathology
March 1, 1996
Cited by 48
Related Papers
Organoid Models of Human and Mouse Ductal Pancreatic Cancer
|Cell|2014|2.2k
Tumor Microsatellite-Instability Status as a Predictor of Benefit from Fluorouracil-Based Adjuvant Chemotherapy for Colon Cancer
|New England Journal of Medicine|2003|2.1k
Chromosome 17 Deletions and p53 Gene Mutations in Colorectal Carcinomas
|Science|1989|2.1k
Incidence and functional consequences of <i>hMLH1</i> promoter hypermethylation in colorectal carcinoma
|Proceedings of the National Academy of Sciences|1998|1.9k
Mutation of a <i>mutL</i> Homolog in Hereditary Colon Cancer
|Science|1994|1.8k